| 4/28/2016 | CV | Market Commentary: Xilinx slides as outlook disappoints; energy names continue to outperform; Chesapeake up
|
| 1/11/2016 | CV | Market Commentary: Energy-related convertibles move lower; other sectors hold in on swap; Depomed drops
|
| 1/11/2016 | CV | Market Commentary: Morning Commentary: Depomed convertibles, shares lower; health care in focus during conference
|
| 12/23/2013 | CV | Market Commentary: United Therapeutics jumps outright, 'comes in' on hedge; Navistar 3% tracks with shares
|
| 12/23/2013 | CV | Market Commentary: Midday Commentary: United Therapeutics jumps outright with shares; Navistar 3% tracks with shares
|
| 10/29/2013 | CV | United Therapeutics' holders may convert 1% convertible senior notes
|
| 3/25/2013 | CV | Market Commentary: Holidays, vacations result in subdued marketplace; Suntech notes jump in late-day trading
|
| 2/14/2013 | CV | Market Commentary: AMR rallies on merger agreement; Coinstar 'comes in;' planned Cliffs upsized, talk tightened
|
| 7/26/2012 | CV | Market Commentary: United Therapeutics gains on hedge after earnings; Cash America down outright, up on hedge
|
| 12/30/2011 | CV | Outlook 2012: Convertibles primary market set for weakness without higher rates, stronger economy
|
| 11/2/2011 | CV | Market Commentary: Human Genome's new $430 million deal prices at 99, edges higher; MF Global adds a little
|
| 10/13/2011 | CV | Market Commentary: Clearwire extends gains on positive quarterly figures; United Therapeutics paper unchanged
|
| 10/12/2011 | CV | New Issue: United Therapeutics sells $250 million five-year convertibles to yield 1%, up 20%
|
| 10/12/2011 | CV | Market Commentary: United Therapeutics prices new issue; EarthLink to redeem 3.25% convertibles; market gains
|
| 10/11/2011 | CV | Market Commentary: Convertibles 'better to buy'; New issue market welcomes new United Therapeutics paper
|
| 10/11/2011 | CV | United Therapeutics to sell $210 million five-year convertible notes at 0.5%-1%, up 20%-25%
|
| 8/25/2011 | CV | Market Commentary: Sellers push Suntech Power lower; United Therapeutics retains gain; Bank of America adds
|
| 8/24/2011 | CV | Market Commentary: Hedge players win on United Therapeutics; Amerigroup adds; investment-grade paper active
|
| 4/6/2010 | CV | Market Commentary: Telvent prices at the cheaps for the yield; Massey Energy contracts on mine blast disaster
|
| 11/16/2007 | CV | Defensive convertibles provide safety in a volatile market, Lehman Brothers report says
|
| 11/1/2007 | CV | Market Commentary: Successful test spurs United Therapeutics; iStar, Countrywide down with financials; tough day for four new issues
|
| 10/30/2006 | BTCV | United Therapeutics greenshoe fully exercised, raising convertibles issue to $250 million
|
| 10/25/2006 | CV | Market Commentary: ImClone slips on board change; Mills gains on offer; United Therapeutics improves; GM slips
|
| 10/24/2006 | CV | Market Commentary: JetBlue climbs on trimmed expansion; Lucent gains on results; United Therapeutics prices deal; L-3 slips
|
| 10/24/2006 | BTCV | New Issue: United Therapeutics prices $210 million convertibles near cheap end, at 0.5%, up 21%
|
| 10/23/2006 | CV | Market Commentary: Connetics soars on buyout; Ford slips; FiberTower could see tough borrow; United Therapeutics plans deal
|
| 10/23/2006 | BTCV | United Therapeutics to price $210 million five-year convertibles, talked at 0%-0.5%, up 20%-24%
|
